Insider Transactions in Q3 2022 at Catalent, Inc. (CTLT)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 26
2022
|
Scott Gunther SVP, Quality & Reg. Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
1,115
+4.67%
|
-
|
|
Jul 26
2022
|
Scott Gunther SVP, Quality & Reg. Affairs |
SELL
Open market or private sale
|
Direct |
450
-2.04%
|
$47,700
$106.9 P/Share
|
|
Jul 26
2022
|
Michael J Grippo SVP, Strategy & Corp. Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
1,301
+6.95%
|
-
|
|
Jul 26
2022
|
Michael J Grippo SVP, Strategy & Corp. Dev. |
SELL
Open market or private sale
|
Direct |
409
-2.48%
|
$43,354
$106.9 P/Share
|
|
Jul 26
2022
|
Aristippos Gennadios Group Pres. Pharma & Consumer |
BUY
Grant, award, or other acquisition
|
Direct |
1,859
+2.23%
|
-
|
|
Jul 26
2022
|
Aristippos Gennadios Group Pres. Pharma & Consumer |
SELL
Open market or private sale
|
Direct |
403
-0.5%
|
$42,718
$106.9 P/Share
|
|
Jul 26
2022
|
Mario Gargiulo SVP, Ops, Biologics Europe |
BUY
Grant, award, or other acquisition
|
Direct |
837
+15.66%
|
-
|
|
Jul 26
2022
|
Mario Gargiulo SVP, Ops, Biologics Europe |
SELL
Open market or private sale
|
Direct |
969
-20.88%
|
$102,714
$106.9 P/Share
|
|
Jul 26
2022
|
Steven L Fasman EVP & Chief Admin Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,788
+4.7%
|
-
|
|
Jul 26
2022
|
Steven L Fasman EVP & Chief Admin Officer |
SELL
Open market or private sale
|
Direct |
2,546
-4.52%
|
$269,876
$106.9 P/Share
|
|
Jul 26
2022
|
John R Chiminski Executive Chair |
BUY
Grant, award, or other acquisition
|
Direct |
37,165
+17.98%
|
-
|
|
Jul 26
2022
|
John R Chiminski Executive Chair |
SELL
Open market or private sale
|
Direct |
9,691
-6.82%
|
$1,027,246
$106.9 P/Share
|
|
Jul 26
2022
|
Thomas P Castellano SVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,323
+11.79%
|
-
|
|
Jul 26
2022
|
Thomas P Castellano SVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
347
-2.25%
|
$36,782
$106.9 P/Share
|
|
Jul 26
2022
|
Lorenzo Carletti SVP Global Ops Ph & Cons Hlth |
BUY
Grant, award, or other acquisition
|
Direct |
837
+18.11%
|
-
|
|
Jul 26
2022
|
Lorenzo Carletti SVP Global Ops Ph & Cons Hlth |
SELL
Open market or private sale
|
Direct |
631
-17.63%
|
$66,886
$106.9 P/Share
|
|
Jul 26
2022
|
Jonathan Arnold SVP, CCO & Div. Head BioP Del. |
BUY
Grant, award, or other acquisition
|
Direct |
1,023
+2.02%
|
-
|
|
Jul 26
2022
|
Jonathan Arnold SVP, CCO & Div. Head BioP Del. |
SELL
Open market or private sale
|
Direct |
94
-0.19%
|
$9,964
$106.9 P/Share
|
|
Jul 01
2022
|
Aristippos Gennadios Group Pres. Pharma & Consumer |
BUY
Grant, award, or other acquisition
|
Direct |
18,689
+18.9%
|
$1,999,723
$107.02 P/Share
|
|
Jul 01
2022
|
Jonathan Arnold SVP, CCO & Div. Head BioP Del. |
BUY
Grant, award, or other acquisition
|
Direct |
2,804
+5.43%
|
$300,028
$107.02 P/Share
|